Blood–brain barrier alterations and their impact on Parkinson’s disease pathogenesis and therapy
Abstract There is increasing evidence for blood–brain barrier (BBB) alterations in Parkinson’s disease (PD), the second most common neurodegenerative disorder with rapidly rising prevalence. Altered tight junction and transporter protein levels, accumulation of α-synuclein and increase in inflammato...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2024-07-01
|
| Edice: | Translational Neurodegeneration |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s40035-024-00430-z |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
